منابع مشابه
The VA HDL intervention trial: clinical implications.
Clinical trials have clearly shown that low density lipoprotein (LDL)-cholesterol lowering reduces coronary heart disease morbidity and mortality in patients with established coronary heart disease and LDL-cholesterol above 3·4 mmol . l . However, about 40% of coronary heart disease patients do not have elevated levels of LDL-cholesterol and many of them have low levels of high density lipoprot...
متن کاملInsulin Dose and Cardiovascular Mortality in the ACCORD Trial
OBJECTIVE In the ACCORD trial, intensive treatment of patients with type 2 diabetes and high cardiovascular (CV) risk was associated with higher all-cause and CV mortality. Post hoc analyses have failed to implicate rapid reduction of glucose, hypoglycemia, or specific drugs as the causes of this finding. We hypothesized that exposure to injected insulin was quantitatively associated with incre...
متن کاملCABG vs. stenting--clinical implications of the SYNTAX trial.
PERSPECTIVE 957 I n a recent article, Yadav et al. 1 elucidated the regulation of gut-produced serotonin by low-density lipoprotein receptor–related protein 5 (Lrp5) and the deleterious effect of serotonin on bone mass. This discovery reflects the rapid advances taking place in bone biology and lends support to three newly understood facts about skeletal physiology. The first fact relates to th...
متن کامل& implications of the RECORD study program Review : Clinical Trial Outcomes
ISSN 2041-6792 10.4155/CLI.11.4 © 2011 Future Science Ltd Rivaroxaban is a direct factor Xa inhibitor that can be administered orally for thromboprophylaxis in orthopedic patients undergoing hip or knee arthroplasty. The new drug is well tolerated with a relatively short half-life and a high bioavailability. Rivaroxaban has undergone an extensive clinical evaluation program in elective orthoped...
متن کاملMonopolizing Clinical Trial Data: Implications and Trends
T he Agreement on Trade-Related Aspects of Intellectual Property Rights (the TRIPS Agreement, Box 1) has to a large extent harmonized standards for intellectual property rights, including patents. For many countries, the TRIPS standards were higher than their previous standards. For example, TRIPS obliges countries to allow patenting of pharmaceuticals and imposes a minimum duration of 20 years...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Clinical Endocrinology & Metabolism
سال: 2012
ISSN: 0021-972X,1945-7197
DOI: 10.1210/jc.2011-1679